240 related articles for article (PubMed ID: 11012203)
1. The role of recombinant interleukin 11 in megakaryocytopoiesis.
Turner KJ; Neben S; Weich N; Schaub RG; Goldman SJ
Stem Cells; 1996; 14 Suppl 1():53-61. PubMed ID: 11012203
[TBL] [Abstract][Full Text] [Related]
2. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.
Goldman SJ
Stem Cells; 1995 Sep; 13(5):462-71. PubMed ID: 8528095
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
Schlerman FJ; Bree AG; Kaviani MD; Nagle SL; Donnelly LH; Mason LE; Schaub RG; Grupp SA; Goldman SJ
Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
5. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice.
Saitoh M; Taguchi K; Momose K; Suga K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Mar; 13(5):287-94. PubMed ID: 11243707
[TBL] [Abstract][Full Text] [Related]
8. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients.
Tomer A; Harker LA
Stem Cells; 1996; 14 Suppl 1():18-30. PubMed ID: 11012199
[TBL] [Abstract][Full Text] [Related]
9. Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recovery.
Warren MK; Zujewski J; Rose WL; Szabo JM; O'Shaughnessy JA; Halverson DC; Cowan KH; Gress RE; Schwartz GN
Stem Cells; 1996; 14 Suppl 1():31-7. PubMed ID: 11012200
[TBL] [Abstract][Full Text] [Related]
10. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.
Orazi A; Cooper RJ; Tong J; Gordon MS; Battiato L; Sledge GW; Kaye JA; Kahsai M; Hoffman R
Exp Hematol; 1996 Sep; 24(11):1289-97. PubMed ID: 8862439
[TBL] [Abstract][Full Text] [Related]
13. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
[TBL] [Abstract][Full Text] [Related]
14. Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage.
Faltynek CR; Wang S; Miller D; Young E; Tiberio L; Kross K; Kelley M; Kloszewski E
J Immunol; 1992 Aug; 149(4):1276-82. PubMed ID: 1500718
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia.
Saitoh M; Taguchi K; Yasuda S; Kikumori M; Nishimori T; Suda M; Okamiya H; Usuda S; Miyata K
J Interferon Cytokine Res; 2000 Jun; 20(6):539-45. PubMed ID: 10888110
[TBL] [Abstract][Full Text] [Related]
16. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
[TBL] [Abstract][Full Text] [Related]
17. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
Fock EL; Yan F; Pan S; Chong BH
Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
[TBL] [Abstract][Full Text] [Related]
18. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
[TBL] [Abstract][Full Text] [Related]
19. Hierarchical structure of human megakaryocyte progenitor cells.
Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
